← back to search

Tanya Jindal

University of California, San Francisco · US
🔎 Find collaborators in Surgery · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Surgery · Oncology
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Urinary and Genital Oncology Studies, and Ferroptosis and cancer prognosis.
h-index
9
citations
356
works
64
NIH funding
primary concept
email

Recent publications

Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study
European Urology 2025cited by 8position: firstdoi
Treatment‐Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the <scp>UNITE</scp> Study
Cancer Medicine 2025cited by 2position: middledoi
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations
JCO Precision Oncology 2024cited by 20position: middledoi
Outcomes with enfortumab vedotin in patients with advanced urothelial carcinoma and histology variants: Analysis of the UNITE study.
Journal of Clinical Oncology 2024cited by 15position: firstdoi
Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor
Clinical Genitourinary Cancer 2024cited by 9position: middledoi
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data
European Urology Oncology 2024cited by 7position: firstdoi
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience
Clinical Genitourinary Cancer 2023cited by 27position: middledoi
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer 2022cited by 23position: middledoi
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
Cancer 2021cited by 82position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ali Raza Khaki · Stanford University2 papers (2022–2024)Shilpa Gupta · Vels University2 papers (2022–2024)Petros Grivas · Second Foundation (United States)2 papers (2022–2024)Vadim S. Koshkin · UCSF Helen Diller Family Comprehensive Cancer Center2 papers (2022–2024)Yousef Zakharia · SUNY Upstate Medical University2 papers (2022–2024)Deepak Kilari · Medical College of Wisconsin1 papers (2024–2024)Jason R. Brown · Case Western Reserve University1 papers (2024–2024)Leonidas Nikolaos Diamantopoulos · Northwell Health1 papers (2022–2022)Charles B. Nguyen · University of Michigan–Ann Arbor1 papers (2024–2024)Alessio Cortellini · Università degli Studi del Piemonte Orientale “Amedeo Avogadro”1 papers (2022–2022)Christopher Hoimes · Duke University1 papers (2024–2024)Amanda Nizam · Cleveland Clinic1 papers (2024–2024)Joaquim Bellmunt · Dana-Farber/Harvard Cancer Center1 papers (2024–2024)Matthew I. Milowsky · UNC Lineberger Comprehensive Cancer Center1 papers (2024–2024)Nishita Tripathi · Wayne State University1 papers (2022–2022)Dimitra Rafailia Bakaloudi · Seattle University1 papers (2022–2022)Roubini Zakopoulou · National and Kapodistrian University of Athens1 papers (2022–2022)Neeraj Agarwal · University of Utah1 papers (2022–2022) · 1 papers (2022–2022)David J. Pinato · Imperial College London1 papers (2022–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Surgery · Oncology →